Life science is our specialty — but not our only lane.

From stealth-mode labs to Series-C ops.

Early-stage biotechs move fast. EHS tends to get bolted on late — usually right before a landlord inspection, a VC diligence round, or the first regulator visit. We help biotech teams build programs that scale from a single BSL-1 lab to multi-site operations without painful rewrites.

Focus areas

• Chemical Hygiene Plans (CHP) and lab-specific SOPs
• Biosafety programs (BSL-1, BSL-2) and IBC support
• HMBP, CUPA, and hazardous waste program setup
• Cell therapy, CRISPR, and gene-modified organism workflows
• Due-diligence prep for landlord, investor, and partner audits

Diagnostics, devices, and contract labs.

Life science operations sit at the intersection of OSHA, EPA, DOT, and often FDA. We build EHS programs that hold up to inspection from any of them — without drowning your ops team in redundant paperwork.

Focus areas

• Analytical and contract lab safety programs
• Medical device R&D and manufacturing EHS
• DOT hazmat shipping programs (49 CFR) and training
• Bloodborne pathogen and medical waste management
• Multi-site rollout and harmonization

Preclinical through commercial manufacturing.

Pharma EHS has to coexist with GMP, with controlled-substance handling, and with process safety for potent compounds. We build programs that satisfy EHS regulators without stepping on quality — and that hold up when inspectors want to see documentation.

Focus areas

• API, HPAPI, and potent compound handling programs
• Controlled substance site management (DEA-adjacent EHS)
• Process safety management (PSM) alignment where applicable
• Hazardous and pharmaceutical waste (RCRA, subpart P) compliance
• Commercial-scale EHS scale-up from R&D operations